Bal Pharma Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Public

  • Employees
  • 939

Employees

  • Stock Symbol
  • 524824

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.91
  • (As of Thursday Closing)

Bal Pharma General Information

Description

Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 5th Floor, Lakshmi Narayan Complex
  • 10/1, Palace Road
  • Bangalore, Karnataka 560052
  • India
+91 080
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • 5th Floor, Lakshmi Narayan Complex
  • 10/1, Palace Road
  • Bangalore, Karnataka 560052
  • India
+91 080

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bal Pharma Stock Performance

As of 19-Nov-2026, Bal Pharma’s stock price is $0.91. Its current market cap is $14.4M with 15.9M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.91 $0.94 $0.63 - $1.31 $14.4M 15.9M 5.37K $0.05

Bal Pharma Financials Summary

As of 30-Jun-2026, Bal Pharma has a trailing 12-month revenue of $36.9M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 28,640 25,319 30,476 33,022
Revenue 36,903 34,288 34,802 39,420
EBITDA 3,910 3,502 3,364 3,801
Net Income 795 711 853 893
Total Assets 39,802 39,244 38,353
Total Debt 0 17,658 17,806 17,058
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bal Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bal Pharma‘s full profile, request access.

Request a free trial

Bal Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bal Pharma Investments (1)

Bal Pharma’s most recent deal was a Early Stage VC with Lifezen Healthcare.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lifezen Healthcare Early Stage VC Pharmaceuticals
To view Bal Pharma’s complete investments history, request access »

Bal Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Bal Pharma’s complete esg history, request access »

Bal Pharma FAQs

  • When was Bal Pharma founded?

    Bal Pharma was founded in 1987.

  • Where is Bal Pharma headquartered?

    Bal Pharma is headquartered in Bangalore, India.

  • What is the size of Bal Pharma?

    Bal Pharma has 939 total employees.

  • What industry is Bal Pharma in?

    Bal Pharma’s primary industry is Pharmaceuticals.

  • Is Bal Pharma a private or public company?

    Bal Pharma is a Public company.

  • What is Bal Pharma’s stock symbol?

    The ticker symbol for Bal Pharma is 524824.

  • What is the current stock price of Bal Pharma?

    As of 19-Nov-2026 the stock price of Bal Pharma is $0.91.

  • What is the current market cap of Bal Pharma?

    The current market capitalization of Bal Pharma is $14.4M.

  • What is Bal Pharma’s current revenue?

    The trailing twelve month revenue for Bal Pharma is $36.9M.

  • What is Bal Pharma’s annual earnings per share (EPS)?

    Bal Pharma’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process